Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02320214 · ClinicalTrials.gov registry record · NA
A Single-Center, Clinical Study to Evaluate the Safety of a Fragranced Personal Lubricant in Healthy Female Subjects
A NA study of Edema and Erythema, sponsored by Church & Dwight Company.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT02320214: Completed NA study of Edema and Erythema, sponsored by Church & Dwight Company.
NCT02320214 is a NA study of Edema and Erythema that has completed, run by Church & Dwight Company. The registered enrollment target is 30 participants, below the 463-participant average among 13 other Edema trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02320214, a NA study of Edema and Erythema, has completed, sponsored by Church & Dwight Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate the safety of Miami w/ frag Personal lubricant when used as indicated as a personal lubricant in the vagina and vulvar/perineal areas at least four times weekly for two weeks in a population of healthy females.
Primary Outcome
Number of participants with observed erythema by OB/GYN examination.
Interventions
- DEVICE Miami w/ frag Personal lubricant
Study Locations (1)
New Jersey
- Clinical Research Laboratories - Piscataway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2014-12 |
| Est. Completion | 2015-01 |
| Phase | NA |
What the finished NCT02320214 record still lists
NCT02320214 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 463-participant average among 13 other Edema trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Edema appearing as the primary indexed condition, and to 1 intervention - of which Miami w/ frag Personal lubricant is the first listed.
NCT02320214 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT02320214 about?
NCT02320214 is a clinical study titled "A Single-Center, Clinical Study to Evaluate the Safety of a Fragranced Personal Lubricant in Healthy Female Subjects". To evaluate the safety of Miami w/ frag Personal lubricant when used as indicated as a personal lubricant in the vagina and vulvar/perineal areas at least four times weekly for two weeks in a population of healthy females.
What is the current status of trial NCT02320214?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2014-12. Estimated completion is 2015-01.
What conditions does trial NCT02320214 study?
This clinical trial studies the following conditions: Edema, Erythema.
What interventions are being tested in trial NCT02320214?
The interventions under investigation include: Miami w/ frag Personal lubricant (DEVICE).
Who is sponsoring clinical trial NCT02320214?
This trial is sponsored by Church & Dwight Company, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02320214 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Edema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02320214's enrollment target sits among peer trials
30 12th of 13 higher than 1 of 13 other Edema trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Edema trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Surgical Evaluation for Upper Extremity Lymphedema (BioBridge)
RECRUITING · NA
-
LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge)
RECRUITING · NA
-
Diuretic Tuner Clinical Decision Support
RECRUITING · NA
-
Foot and Ankle Post-operative Oedema Management Using Geko™
COMPLETED · NA
-
Human Repeat Insult Patch Test to Evaluate Personal Lubricants
COMPLETED · NA
-
A Single-Center, Clinical Study to Evaluate the Safety of a New Personal Lubricant in Healthy Female Subjects
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia